| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 268.00M | — |
| Operating expense | — | — |
| Net income | -115.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ISI.F returned +48.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -20.0% |
| 1 year | +48.8% |
| 5 years | +62.9% |
| 10 years | +103.5% |
| All-time high | €70.86 (Mar 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ISI.F would be worth today ›No. Ionis Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Ionis Pharmaceuticals, Inc. is part of the Healthcare sector.
Ionis Pharmaceuticals, Inc. has a market cap of 8.95B EUR, based on the latest quote.